On Monday, Harvard Bioscience Inc (NASDAQ: HBIO) was -5.70% drop from the session before settling in for the closing price of $0.7. A 52-week range for HBIO has been $0.28 – $2.28.
A company in the Healthcare sector has dropped its sales by -18.10% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 0.00%. With a float of $38.25 million, this company’s outstanding shares have now reached $44.58 million.
Harvard Bioscience Inc (HBIO) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Harvard Bioscience Inc stocks. The insider ownership of Harvard Bioscience Inc is 14.19%, while institutional ownership is 36.00%.
Harvard Bioscience Inc (HBIO) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 0.06 earnings per share (EPS) during the time that was better than consensus figure (set at 0.05) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.00% per share during the next fiscal year.
Harvard Bioscience Inc (NASDAQ: HBIO) Trading Performance Indicators
You can see what Harvard Bioscience Inc (HBIO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.34. Likewise, its price to free cash flow for the trailing twelve months is 4.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.22, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.10 in one year’s time.
Technical Analysis of Harvard Bioscience Inc (HBIO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.41 million. That was inferior than the volume of 4.96 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 14.14%.
During the past 100 days, Harvard Bioscience Inc’s (HBIO) raw stochastic average was set at 50.81%, which indicates a significant increase from 0.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0559 in the past 14 days, which was higher than the 0.0498 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6286, while its 200-day Moving Average is $0.5024. However, in the short run, Harvard Bioscience Inc’s stock first resistance to watch stands at $0.6975. Second resistance stands at $0.7328. The third major resistance level sits at $0.7505. If the price goes on to break the first support level at $0.6445, it is likely to go to the next support level at $0.6268. The third support level lies at $0.5915 if the price breaches the second support level.
Harvard Bioscience Inc (NASDAQ: HBIO) Key Stats
There are 44,580K outstanding shares of the company, which has a market capitalization of 29.53 million. As of now, sales total 94,140 K while income totals -12,410 K. Its latest quarter income was 20,590 K while its last quarter net income were -1,230 K.
